In both the control and imatinib groups, the intensity of Ki67 staining (Figure 6B) exhibited pronounced fluorescence in the spleen, indicating the splenic infiltration of CML cells. Here, MKI67 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.